Replies to post #244149 on Biotech Values

[Biowatch]

AZ_Drug_Slows_Mental_Decline_in_Trial—But_Breakthrough?

By McKenzie Prillaman, Nature magazine on September 30, 2022

https://www.scientificamerican.com/article/alzheimers-drug-slows-mental-decline-in-trial-but-is-it-a-breakthrough

You’re probably right about it being a benefit to those “on the pathway to profit” even if they have no clue how to treat the disease.

Keep in mind, baby boomers, and their parents, are getting steadily older, so the incidence of dementia in all forms will increase with time.